Analysis of the cross-talk of Epstein-Barr virus-infected B cells with T cells in the marmoset

Dunham, J., van Driel, N., Eggen, B. J., Paul, C., 't Hart, B. A., Laman, J. D. & Kap, Y. S., 10-Feb-2017, In : Clinical & translational immunology. 6, p. 1-13 13 p.

Research output: Contribution to journalArticleAcademicpeer-review

Despite the well-known association of Epstein-Barr virus (EBV), a lymphocryptovirus (LCV), with multiple sclerosis, a clear pathogenic role for disease progression has not been established. The translationally relevant experimental autoimmune encephalomyelitis (EAE) model in marmoset monkeys revealed that LCV-infected B cells have a central pathogenic role in the activation of T cells that drive EAE progression. We hypothesized that LCV-infected B cells induce T-cell functions relevant for EAE progression. In the current study, we examined the ex vivo cross-talk between lymph node mononuclear cells (MNCs) from EAE marmosets and (semi-) autologous EBV-infected B-lymphoblastoid cell lines (B-LCLs). Results presented here demonstrate that infection with EBV B95-8 has a strong impact on gene expression profile of marmoset B cells, particularly those involved with antigen processing and presentation or co-stimulation to T cells. At the cellular level, we observed that MNC co-culture with B-LCLs induced decrease of CCR7 expression on T cells from EAE responder marmosets, but not in EAE monkeys without clinically evident disease. B-LCL interaction with T cells also resulted in significant loss of CD27 expression and reduced expression of IL-23R and CCR6, which coincided with enhanced IL-17A production. These results highlight the profound impact that EBV-infected B-LCL cells can have on second and third co-stimulatory signals involved in (autoreactive) T-cell activation.

Original languageEnglish
Pages (from-to)1-13
Number of pages13
JournalClinical & translational immunology
Publication statusPublished - 10-Feb-2017


  • Journal Article

Download statistics

No data available

ID: 40156814